High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy

BackgroundProstate cancer is one of the leading causes of cancer death amongst men in economically advanced countries. The disease is characterized by a greatly varying clinical course, where some patients harbor non- or slowly-progressive disease, others highly aggressive disease. There is a great lack of markers to differentiate between aggressive and indolent disease. Markers that could help to identify patients needing curative treatment while sparing those who do not.MethodsMicroRNA profiling of 672 microRNAs using multiplex RT-qPCR was performed using 36 prostate cancer samples to evaluate the association of microRNAs and biochemical recurrence after radical prostatectomy.ResultsAmong 31 microRNAs associated with recurrence, we identified miR-449b, which was further validated in an independent cohort of 163 radical prostatectomy patients. Patients expressing miR-449b had a significantly higher risk of recurrence (HR = 1.57; p = 0.028), and miR-449b was shown to be an independent predictor of recurrence after prostatectomy (HR = 1.9; p = 0.003) when modeled with known risk factors of recurrent disease in multivariate analysis.ConclusionHigh miR-449b expression was shown to be an independent predictor of biochemical recurrence after radical prostatectomy.

[1]  W. Isaacs,et al.  Detection and analysis of β‐catenin mutations in prostate cancer , 2000 .

[2]  W. Isaacs,et al.  Detection and analysis of beta-catenin mutations in prostate cancer. , 2000, The Prostate.

[3]  M. Roobol,et al.  Prevalence and characteristics of screen‐detected prostate carcinomas at low prostate‐specific antigen levels: aggressive or insignificant? , 2005, BJU international.

[4]  Paula K Shireman,et al.  Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis , 2009 .

[5]  F. Hamdy,et al.  Changes in circulating microRNA levels associated with prostate cancer , 2012, British Journal of Cancer.

[6]  F. Ahmed.  Role of miRNA in carcinogenesis and biomarker selection: a methodological view , 2007, Expert review of molecular diagnostics.

[7]  Holger Sültmann,et al.  Circulating miRNAs are correlated with tumor progression in prostate cancer , 2011, International journal of cancer.

[8]  C. Stephan,et al.  miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression. , 2011, International journal of oncology.

[9]  Paul Polakis,et al.  Wnt signaling in cancer. , 2012, Cold Spring Harbor perspectives in biology.

[10]  Qiang Yu,et al.  miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A. , 2009, Genes & development.

[11]  B. Frenkel,et al.  Lef1 Haploinsufficient Mice Display a Low Turnover and Low Bone Mass Phenotype in a Gender- and Age-Specific Manner , 2009, PloS one.

[12]  C. Tepper,et al.  microRNAs and prostate cancer , 2008, Journal of cellular and molecular medicine.

[13]  M. Dobbelstein,et al.  E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis , 2010, Cell Death and Differentiation.

[14]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[15]  C. Croce,et al.  MicroRNA expression and function in cancer. , 2006, Trends in molecular medicine.

[16]  W. Isaacs,et al.  In vitro evidence for complex modes of nuclear β-catenin signaling during prostate growth and tumorigenesis , 2002, Oncogene.

[17]  A. Eklund,et al.  MicroRNA profile analysis of human prostate cancers , 2009, Cancer Gene Therapy.

[18]  K. D. Sørensen,et al.  DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  P. Birembaut,et al.  Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta/Notch pathway , 2011, Nature Cell Biology.

[20]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[21]  T. Ørntoft,et al.  SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation. , 2008, Histology and histopathology.

[22]  L. Klotz.  Active Surveillance for Prostate Cancer: Overview and Update , 2013, Current Treatment Options in Oncology.

[23]  R. Stephens,et al.  Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. , 2008, Cancer research.

[24]  O. Kent,et al.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes , 2006, Oncogene.

[25]  C. Scholz,et al.  Expression of microRNA‐221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence , 2009, International Journal of Cancer.

[26]  R. Place,et al.  miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells , 2010, Oncotarget.

[27]  Z. Hall.  Cancer , 1906, The Hospital.

[28]  S. Terry,et al.  Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer , 2006, Journal of cellular biochemistry.

[29]  B. G. Blijenberg,et al.  Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.

[30]  S. Hammond,et al.  MicroRNAs as oncogenes. , 2006, Current opinion in genetics & development.

[31]  T. Tammela,et al.  MicroRNA expression profiling in prostate cancer. , 2007, Cancer research.

[32]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[33]  Biliang Zhang,et al.  Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells. , 2014, Cancer letters.

[34]  R. Place,et al.  miR-449a targets HDAC-1 and induces growth arrest in prostate cancer , 2009, Oncogene.

[35]  G. Kristiansen,et al.  Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma , 2009, International journal of cancer.

[36]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[37]  C. Creighton,et al.  Widespread deregulation of microRNA expression in human prostate cancer , 2008, Oncogene.

[38]  J. W. Lee,et al.  miR-449a regulates the chondrogenesis of human mesenchymal stem cells through direct targeting of lymphoid enhancer-binding factor-1. , 2012, Stem cells and development.

[39]  George A. Calin,et al.  Expression of microRNAs and protein‐coding genes associated with perineural invasion in prostate cancer , 2008, The Prostate.

[40]  L. Holmberg,et al.  Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. , 2012, European urology.

[41]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.